IMMUNOHISTOCHEMISTRY, TSH

The IHC – TSH (Thyroid Stimulating Hormone) test is an immunohistochemistry-based diagnostic assay used to detect TSH protein expression in tissue samples. TSH is a hormone produced by specialized cells called thyrotrophs in the anterior pituitary gland. It plays a crucial role in regulating thyroid gland function and controlling the production of thyroid hormones.

This test is primarily used in pathology to identify and classify pituitary adenomas and other endocrine tumors that produce TSH. Detection of TSH within tumor cells helps pathologists determine the cellular origin and functional status of pituitary neoplasms. It is especially valuable when evaluating pituitary masses associated with hormonal abnormalities or suspected hormone-secreting tumors.

The IHC TSH test is an important component of comprehensive pituitary tumor profiling and is often used alongside other pituitary hormone markers to achieve an accurate diagnosis.

Benefits of the Test

• Helps diagnose TSH-producing pituitary adenomas
• Assists in identifying hormone-secreting pituitary tumors
• Supports classification of endocrine neoplasms
• Improves diagnostic accuracy in pituitary pathology
• Helps guide treatment planning and prognosis assessment

Why Doctors Recommend This Test

Doctors recommend the IHC TSH test when evaluating pituitary gland tumors and endocrine disorders. It is commonly used in:

• TSH-secreting pituitary adenoma diagnosis
• Pituitary tumor classification
• Endocrine neoplasm evaluation
• Investigation of pituitary masses
• Assessment of hormone-producing tumors
• Neuroendocrine pathology studies

TSH is frequently evaluated alongside other pituitary hormones such as Prolactin, Growth Hormone (GH), ACTH, FSH, LH, and Ki-67 to provide a complete hormonal profile of pituitary tumors.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting is required
• No medication restrictions are generally necessary
• Hormonal laboratory results and imaging findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected pituitary adenoma
• Individuals with abnormal thyroid hormone regulation caused by pituitary disease
• Patients undergoing pituitary tumor surgery
• Cases requiring endocrine tumor classification
• Endocrinology and oncology patients requiring immunohistochemistry profiling

The IHC TSH test is an important diagnostic tool in endocrine pathology. By identifying TSH-producing cells within tumors, it helps clinicians accurately classify pituitary neoplasms and develop effective treatment strategies.

Clinical Significance

TSH immunostaining is commonly used in the evaluation of:

• TSH-secreting pituitary adenoma (thyrotroph adenoma)
• Functional pituitary tumors
• Pituitary neuroendocrine tumors (PitNETs)
• Sellar region tumors
• Endocrine gland neoplasms
• Hormone-producing pituitary lesions

Positive TSH staining supports thyrotroph differentiation and helps confirm the diagnosis of TSH-producing pituitary tumors.